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Depression and HIV-related stigma, among other factors, have been inversely linked independently with adherence to 
antiretroviral therapy (ART) among the youth. However, the processes through which the various factors influence this 
relationship is not fully known. Guided by Social Action Theory, we examined the interactive mechanisms through 
which depression, HIV-related stigma, and self-efficacy influenced ART adherence and whether or not these 
relationships are moderated by gender. A total of 450 HIV-positive youth (13–24 years) in Malawi receiving ART 
participated in this cross-sectional study. Moderated mediation analyses were conducted using Hayes’ PROCESS 
macro 2.11 in SPSS. ART adherence was measured by pill count. Findings showed that self-efficacy mediated the 
effects of depression and stigma on ART adherence. The analyses also revealed that gender moderated both the direct 
and indirect influence of depression and stigma (via self-efficacy) on ART adherence. Furthermore, self-efficacy 
simultaneously mediated and moderated the relationship between stigma and ART adherence. The interactive 
mechanisms through which various factors influence ART nonadherence must be considered to design effective 
interventions. To reduce the impact of depression and stigma on ART adherence, medication self-efficacy should be 
bolstered while taking gender in consideration. 
 




Pengaruh Efikasi Diri Terhadap Hubungan antara Depresi dan Stigma HIV dengan Kepatuhan Terapi ART pada 
Remaja di Malawi. Depresi dan stigma HIV, di antara faktor-faktor lain, berhubungan terbalik secara independen 
dengan kepatuhan terapi antiretroviral (ART) pada remaja. Akan tetapi, dalam prosesnya faktor yang memengaruhi 
hubungan ini belum sepenuhnya diketahui. Berdasarkan Teori Perilaku Sosial, penelitian ini dilakukan bertujuan untuk 
mengkaji mekanisme interaktif depresi, stigma HIV, dan efikasi diri yang memengaruhi kepatuhan ART, dan untuk 
mengetahui apakah hubungan ini dimoderasi oleh gender atau tidak. Sebanyak 450 remaja dengan HIV-positif (13–24 
tahun) di Malawi yang menerima ART ikut berpartisipasi dalam penelitian potong lintang ini. Analisis mediasi 
moderated dilakukan dengan menggunakan Hayes 'PROCESS macro 2.11 pada SPSS. Kepatuhan ART diukur 
menggunakan jumlah pil. Hasil penelitian menunjukkan bahwa efikasi diri memediasi efek depresi dan stigma pada 
kepatuhan ART. Hasil analisis juga mengungkapkan bahwa jenis kelamin memoderasi pengaruh langsung dan tidak 
langsung dari depresi dan stigma (melalui efikasi diri) terhadap kepatuhan ART. Lebih lanjut,efikasi diri secara 
bersamaan mediasi dan moderasi hubungan antara stigma dan kepatuhan ART. Mekanisme interaktif dengan berbagai 
faktor yang memengaruhi ketidakpatuhan ART harus dipertimbangkan untuk merancang intervensi yang efektif. Untuk 
mengurangi dampak depresi dan stigma terhadap kepatuhan ART, efikasi diri pengobatan harus didukung saat 
mempertimbangkan jenis kelamin. 
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Advances in antiretroviral therapy (ART) have 
transformed HIV into a chronic condition for 
those with access and adherence to treatment 
(Hawkins, et al., 2016). Although AIDS-rela-
ted mortality has gradually declined in other 
age groups, emerging evidence indicates that it 
is increasing among adolescents and young 
people worldwide (Bekker, Johnson, Wallace, 
& Hosek, 2015). These trends have been 
linked to poor ART adherence among adole-
scents and young people. Studies show that 
numerous factors influence adolescents’ adhe-
rence to ART (Kim, Gerver, Fidler, & Ward, 
2014; Taddeo, Egedy, & Frappier, 2008). An 
understanding of the mechanisms through 
which these factors affect ART adherence a-
mong adolescents and young people in specific 
contexts is needed to develop and implement 
effective interventions (Hudelson & Cluver, 
2015). 
 
Approximately 80% of adolescents living with 
HIV are in sub-Saharan Africa (SSA) (UNICEF, 
2016). Malawi is one of the countries in the 
region with an HIV prevalence rate of 10.8% 
and is ranked 9th in the world. Young people 
in Malawi bear a higher burden of HIV com-
pared with other age groups. In 2015, they 
accounted for 50% of new HIV infections with 
an estimated 3.6% of young women and 2.5% 
of young men (age 15–24 years) living with 
HIV (Avert, 2016). 
 
With high levels of new HIV infection among 
young people combined with the successful 
scale up of pediatric HIV care, the population 
of adolescents living with HIV is likely to 
increase. This emerging group of young peo-
ple living with HIV must adhere to their tre-
atment regimens to ensure a better quality of 
life and prevent onward HIV transmission as 
they navigate adolescence. Unfortunately, stu-
dies show that adolescents and young people 
comprise the lowest adherent age group re-
lative to other age groups (Cluver, et al., 
2016). 
 
Among other factors, research indicates a 
strong association between depression and 
HIV-related stigma with suboptimal ART ad-
herence among adolescents and young people 
living with HIV. Self-efficacy also has been 
linked with optimal ART adherence (Kekwa-
letswe, Jordaan, Nkosi, & Morojele, 2016). 
Research on youth revealed an association 
between ART adherence and factors such as 
demographic characteristics including age   
and education, family context, peer support, 
and treatment side effects (Taddeo, et al., 
2008). 
 
The prevalence of depression among people 
living with HIV is estimated to be double that 
of the general population; adolescents and yo-
ung people living with the virus are especially 
vulnerable (Kim, et al., 2015). For example, a 
Malawi study found that nearly 19% of ado-
lescents (12–18 years) living with HIV in the 
country are depressed and depression is in-
dependently associated with a few years of 
schooling and being bullied for taking medi-
cation (Kim, et al., 2015). Other factors asso-
ciated with depression among adolescents and 
young people include experiences of death in 
the family, not having disclosed or sharing a 
positive HIV status with someone, and severe 
immunosuppression (Dow, et al., 2016; Kim, 
et al., 2015). 
 
High levels of stigma were reported among 
people living with HIV in the few studies con-
ducted in Malawi (Kamen, et al., 2016). A 
number 22% prevalence of anticipated stigma 
was found among Malawians who were of-
fered home-based HIV testing (MacPherson, et 
al., 2011). A multi-country study in SSA that 
included Malawi found that HIV stigma a-
mong people living with HIV and their nurse 
health providers varies from 6.6% to 13.4% 
(Holzemer, et al., 2009). Other studies in SSA 
that included Malawi found a relationship bet-
ween HIV stigma and missed doses of ART 
(Dlamini, et al., 2009). Stigma limits adole-
scents’ HIV disclosure to friends and even fa-
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mily who may be a source of support for them 
in taking their medication (Aderomilehin, 
Hanciles-Amu, & Ozoya, 2016). It also raises 
youth’s fears of being discovered to be HIV-
positive, a worry that can prevent them from 
taking their medication in the presence of 
people unaware of their status. Despite its im-
portance, no study has examined the associa-
tion between HIV-related stigma and ART 
adherence within the Malawian context (Ade-
romilehin, et al., 2016). Furthermore, no known 
study has examined   the interplay of these va-
riables in influencing ART adherence among 
adolescents and young people. 
 
High levels of ART adherence are necessary 
for adolescents to benefit individually from 
ART, as well as for public health benefits to be 
realized. Although ART adherence interven-
tions are known to be more effective if they 
consider the complexity of mechanisms thro-
ugh which various factors intersect to influ-
ence ART adherence, most adherence studies 
in SSA have focused on single variables (Hu-
delson & Cluver, 2015). In addition, few stu-
dies focused globally on the interactive me-
chanisms through which various factors in-
fluence ART adherence or have examined 
mediational effects of self-efficacy on the 
relationship between depression and stigma 
with adherence (Hudelson & Cluver, 2015; 
Wagner, et al., 2016). Meanwhile, studies on 
the possible influence of gender on adolescent 
ART adherence have yielded contradictory 
findings regarding its effects (Ioannides, et al., 
2017). 
 
In contrast to previous research in SSA, we 
went beyond examining direct associations of 
various factors with ART adherence. Instead, 
we sought to examine the potential mecha-
nisms through which stigma and depression 
impact youth’s adherence to ART and whether 
or not the mediational effects of self-efficacy 
are contingent on one or more factors. The stu-
dy utilized social action theory (SAT) as a gui-
ding framework to test moderated mediation 
models of self-efficacy and gender on the re-
lationship between HIV-related stigma and 
depression with ART adherence (Ewart, 1991). 
SAT posits that health protective behavior, 
which is ART adherence in this study, results 
from three interactive domains: the environ-
mental context, which includes sociodemogra-
phic variables including gender; responses to 
internal affective states, such as depression 
and HIV stigma; and the self-regulation capa-
cities of the individual, such as defined by 
self-efficacy (Bekker, et al., 2011; Hawkins, et 
al., 2016; Johnson, et al., 2003; Kim, et al., 
2014; Taddeo, et al., 2008). 
 
On the basis of SAT, a self-regulatory factor 
(self-efficacy) is hypothesized to mediate the 
relations between the environmental contextu-
al factors (depression and stigma) with action 
state factors (ART adherence). This media-
tional effect is expected to depend on gender. 
Stigma is also expected to moderate its in-
direct effect on ART adherence via self-effi-
cacy. 
 
Specifically, the study analyzed the following 
hypotheses: 
 
Hypothesis 1: Self-efficacy mediates the rela-
tionship between depression 
and ART adherence; 
Hypothesis 2: Self-efficacy mediates the rela-
tionship between stigma and 
ART adherence; 
Hypothesis 3: Gender moderates the direct 
and the mediational effects of 
self-efficacy on the relationship 
between depression and ART 
adherence; 
Hypothesis 4: Gender moderates the direct 
and the mediational effects of 
self-efficacy on the relationship 
between stigma and ART adhe-
rence; 
Hypothesis 5: Self-efficacy simultaneously me-
diates and moderates the rela-
tionship between stigma and 
ART adherence. 
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This study was conducted in six district hos-
pitals in southern Malawi, a region of the 
country with an HIV prevalence rate that is 
twice that of northern and central Malawi 
(Avert, 2015). The study was approved for the 
protection of research subjects by the Insti-
tutional Review Boards of the University of 
Illinois at Chicago and the University of 
Malawi’s College of Medicine Research and 
Ethics Committee. 
 
Subjects for this study were adolescents and 
young people (13–24 years) living with HIV in  
Southern Malawi. A total of 450 adolescents 
and young people were involved in face-to-
face structured interviews, lasting between 50 
min and 1 hour. Potential subjects were all 
young people (13–24 years of age) who had 
ever registered to start ART at one of the six 
clinics. Criteria for screening and enrollment 
included 1) being an HIV-positive male or 
female between 13 and 24 years of age, 2) 
being aware of their HIV-positive status, and 
3) having been registered to be on ART for at 
least the past 6 months. All potential subjects 
who contacted the researchers and met the 
enrollment criteria participated in the study. 
 
Subjects between 18 and 24 years of age pro-
vided voluntary informed consent, whereas 
those ages 13–17 years provided informed 
assent along with approval by a parent or 
guardian. In appreciation of their time in being 
interviewed, participants were reimbursed for 
transport expenses and given a snack before 
the interviews. 
 
Data were collected by two research assistants 
and the senior investigator who administered a 
questionnaire to the youth. The questionnaire 
contained demographic questions and measu-
res for various key factors. Visual prompt 
cards were used to facilitate responses for 
questions that required respondents to provide 
Likert responses. The questionnaire, consent, 
and assent forms were translated and back-
translated between English and Chichewa or 
Yao. Interviews were conducted in either lang-
uage based on the respondent’s preference. 
 
Demographics and clinical characteristics were 
obtained by asking the participants to self-
report their age, gender, how long they had 
known they were HIV-positive, and their high-
est level of education. Patient records were 
used to determine when they had been diag-
nosed and how long they had been on ART. 
Apart from gender, all demographic variables 
were measured as continuous values. ART 
adherence was assessed using pill count per-
centages abstracted from the youth’s electronic 
medical records (EMRs) as these have been 
found reliable in determining ART adherence 
(Wu, et al., 2014). The EMR calculates ART 
adherence rates based on the number of un-
used pills in the container that the youth 
brought back when refilling their medication. 
Given that the last recorded adherence rate 
occurred within 30 days of data collection, the 
abstracted score reflects a 30-day window pe-
riod. HIV-related stigma was assessed using the 
HIV/AIDS Stigma Instrument–PLWA (HASI-
P). This measure was developed in five sub-
Saharan African countries including Malawi 
and it has been used in several studies in the 
region (Sorsdahl, Mall, Stein, & Joska, 2011; 
Uys, et al., 2009).  
 
The measure consists of six subscales: verbal 
abuse (8 items), negative self-perception (5 
items), health care neglect (7 items), social 
isolation (5 items), fear of contagion (6 items), 
and workplace stigma (2 items) (Holzemer, et 
al., 2007). The negative self-perception sub- 
scale measures internalized stigma, while the 
remaining five subscales measure enacted stig-
ma. Internalized stigma refers to an individu-
al’s unpleasant beliefs toward themselves after 
incorporating negative views from others, whe-
reas enacted stigma refers to an individual’s 
real experience from external discrimination af-
ter disclosure of their HIV-positive status 
(Zhang, et al., 2016). In the current study, the 
two workplace items were adapted to suit ado-
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lescents, most of whom were unemployed. For 
example, the item ―My employer denied me 
opportunities‖ was revised to say, ―My teach-
er/team/group leader denied me opportunities.‖ 
The items for the HASI-P were scored from 
0-never; 1-once or twice; 2-several times; and 
three-most of the time. In the current study, 
Cronbach’s alpha was 0.93. Depressive symp-
toms were assessed using the Self-Reporting 
Questionnaire (SRQ 20). The SRQ is a brief 
measure of psychiatric symptomatology, de-
signed by WHO to be used cross-culturally as 
a measure for screening common mental dis-
orders. The measure consists of 20 questions 
with ―yes‖ or ―no‖ answers. The SRQ was 
previously validated in Malawi and has been 
used with women in several studies (Stewart, 
Umar, Tomenson, & Creed, 2013). The raw 
SRQ score is the total of ―yes‖ items out of the 
20. In the current study, Cronbach’s alpha was 
0.83. ART adherence self-efficacy was mea-
sured by the Adherence Self-Efficacy Scale, 
which is a 12-item scale used to measure pa-
tient confidence in carrying out important tre-
atment-associated behaviors related to perse-
verance and integration of treatment into one's 
life (Johnson, et al., 2007). Responses range 
from 1 (cannot do it) to 10 (certain can   do it), 
with a high score indicating great self-efficacy. 
The ASE demonstrated robust internal con-
sistency (rhos> 0.90) and 3 (rs> 0.70) and 15 
months (rs> 0.40) test–retest reliability 
(Johnson, et al., 2007). This scale was trans-
lated-back-translated by two bilingual people 
because it had never been validated in Malawi. 
In this study, Cronbach’s alpha was 0.81. 
 
Descriptive statistics were calculated to des-
cribe the sample characteristics (Table 1). Cor-
relational analyses determined if study vari-
ables were significantly associated with ART, 
the study’s dependent variable (Table 2). To 
investigate the proposed hypotheses, mediated 
regression analyses followed by moderated me-
diation analyses were carried out using Hayes’ 
PROCESS macro 2.11 for SPSS version 22 
(Hayes, 2013). 
 
Mediation analysis tested the effects of HIV-
related stigma and depression as independent 
variables on ART adherence, with self-effica-
cy as a mediator variable by applying PRO-
CESS model 4 with 5000 bootstraps and 95% 
confidence level. The age, gender, educational 
level, and period of knowing that they were 
HIV-positive were entered as covariates to 
control for their influence. Bootstrapping in 
PROCESS provides lower and upper level 
confidence intervals (LLCIs and ULCIs). The 
effect is considered significant if the range of 
these limits does not straddle zero (Hayes, 
2013). Given a significant mediation effect, we 
then tested a moderated mediation model to 
examine if the simple mediation models held 
given the level of independent variables (dep-
ression and/or stigma), or gender. Moderated 
mediation allows researchers to assess both 
how and when an indirect effect of an inde-
pendent variable on a dependent occurs (Blas-
hill & Vander Wal, 2010). 
 
Moderated mediation analyses were conducted 
using PROCESS models 15 and 74. PROCESS 
combines mediation and moderation through 
the construction and estimation of conditional 
process models. It allows the direct and/or in-
direct effects of independent variable X on a 
dependent variable Y through one or more me-
diators (M) to be moderated. When there is 
moderation of the effect of X on M, effect of M 
on Y, or both, estimation of the inference (con-
ditional indirect effect) of X provides insight 
into the contingent nature of the dependent 
variable’s effect on the dependent variable 
through the mediator(s), depending on the mo-
derator (Hayes, 2013). 
 
The current analysis used PROCESS model 15 
to test two moderated mediation models. The 
first model entered depression as the indepen-
dent variable, with self-efficacy as the medi-
ator and gender as a moderator. The second 
model considered stigma as an independent 
variable, with self-efficacy as the mediator and 
gender as the moderator. The moderator (gen- 
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der) was tested for both direct and indirect 
effects in the two models. A third model, using 
PROCESS model 74, considered stigma as the 
independent variable and moderator, while self-
efficacy acted as the mediator variable. 
 
Moderated mediation explains both how and 
when a given effect occurs. Moderated me-
diation effects may occur in multiple ways 
(Preacher, Rucker, & Hayes, 2007). In this 
analysis, two ways were proposed. First, a se-
parate variable (gender) would moderate the 
mediated effect of HIV-related stigma and de-
pression, with ART adherence as the direct 
effect. Second, an independent variable (HIV-
related stigma) would function as a moderator 
of the pathway from the mediator to the de-
pendent variable (ART adherence). All conti-
nuous variables were mean centered. Gender 




Table 1 reports the demographic characteris-
tics of the participants. Nearly two-thirds 
(59.8%) were female, and most were primary 
school educated (64.2%). Table 2 presents in-
ter-correlations of variables of interest. Stigma 
and depression were both significantly and ne-
gatively correlated with ART adherence (r= -
0.240, p< 0.001 and r= -0.155, p< 0.001 
respectively). Self-efficacy was significantly 
and positively correlated with ART adherence 
(r= 0.222, p< 0.001). 
 
 
Table 1. Characteristics of The Sample (N = 450) 
 
Variable Mean SD N % 
ART adherence 86.30 (17.75)   
     
Depression 4.93 (4.10)   
     
HIV-related stigma 5.86 (11.12)   
     
Age in years 16.72 (2.99)   
     
Years on ART 5.73 (2.99)   
     
Years aware of HIV-positive status 4.82 (3.15)   
     
Gender     
Male   181 (40.2) 
Female   269 (59.8) 
     
Education level     
Primary school   289 (64.2) 
Secondary school   152 (33.8) 
College education   9 (2.0) 
 
 
Table 2. Correlations among Study Variables 
 
 Adherence Self-efficacy Depression Stigma Age Years Status 
Adherence 1      
Self-Efficacy .222
**
 1     
Depression -.155
**





 .406** 1   
Age .117* -.005 .090 .112* 1  
Years Status
a 
.111* .100* -.005 -.067 .259** 1 
 
a
 Years Status Years youth has known his or her HIV-positive status 
**. Correlation is significant at the 0.01 level (2-tailed) 
*. Correlation is significant at the 0.05 level (2-tailed) 
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Table 3. Coefficients and Confidence Intervals for Depression, Self-Efficacy, Gender, and Art Adherence in 




Coeff. SE t p LLCI ULCI 
Depression to Self-efficacy -0.094 0.017 -5.397 <0.001 -0.128 -0.721 
Self-efficacy to Adherence 1.9478 0.606 3.216 0.001 0.758 3.138 
Depression to Adherence 
(controlling for S-E) 
-0.437 0.223 -1.953 0.051 -0.876 0.003 
Gender 0.169 1.534 0.110 0.912 -2.846 3.186 
Self-efficacy x gender -3.302 1.212 -2.725 0.006 -5.683 -0.921 
Depression x gender -0.395 0.430 -0.919 0.358 -1.240 0.450 
 
Conditional direct effect of depression on adherence at values of the moderator (male/female) 
Mediator Moderator Coeff. SE t  BootLLCI BootULCI 
Self-efficacy Male -0.200 0.3189 -0.6203  -0.827 0.427 
Self-efficacy Female -0.058 0.2992 -1.9901  -1.183 -0.007 
 
Conditional indirect effect of depression on adherence at values of moderator (male/female) 
Mediator Moderator Coeff. BootSE   BootLLCI BootULCI 
Self-efficacy Male -0.368 0.1102   -0.620 -0.189 
Self-efficacy Female -0.058 0.0743   -0.219 0.074 
 
Index of moderated mediation 
Mediator Index  SE (Boot)   BootLLCI BootULCI 
Self-efficacy 0.3101  0.1310   0.092 0.606 
 
Dep: depression, SE: standard error, S-E: self-efficacy 
a
 Controlling for age, educational status, period known to be HIV-positive 
 
 
Subsequently, we examined the mediation ef-
fect of self-efficacy on the relation between 
depresion and ART adherence (Hypothesis 1). 
The results revealed a significant partial me-
diation effect (Sobel test for indirect effect, Z= 
-2.92, P= 0.0035). We also examined the 
mediation effect of self-efficacy on the relation 
between stigma and ART adherence (Hypothe-
sis 2). These results also revealed a significant 
partial mediation effect (Sobel test for indirect 
effect, Z= -2.13, P= 0.0327). 
 
After establishing the mediational effects of 
self-efficacy on the relations between depres-
sion and stigma with ART adherence, we exa-
mined moderated mediation models involving 
depression and HIV-related stigma as inde-
pendent variables, self-efficacy as both media-
tor and moderator, and gender as moderator 
(Hypothesis 2). 
Hypothesis 3 posited that gender would media-
te both the direct and the mediational effect of 
self-efficacy on the relationship between de-
pression and ART adherence. Table 3 shows 
the results. For indirect effects, the analysis 
revealed that depression predicted self-efficacy 
(B= -0.09, t= -5.39, P< 0.001), with high 
scores of depression predicting low levels of 
self-efficacy. The interaction term in the ana-
lysis, self-efficacy x gender, significantly pre-
dicted ART adherence beyond the independent 
main effects of self-efficacy and gender (B= -
3.30, t= -2.73, P= 0.0067). The analysis tested 
the indirect conditional effects at two levels 
(male, female), and the results depicted self-
efficacy serving as a mediator in the relation-
ship between depression and ART adherence 
for males (B= -.36, BootLLCI= -0.61, Boot-
LLCI= -0.17) only but not females (B= -.05, 
BootLLCI= -0.21, BootLLCI= 0.07). The boot- 
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Table 4. Coefficients and Confidence Intervals for Stigma, Self-Efficacy, Gender, and Art Adherence in The 
Mediation Model 
 
Source  Coeff. SE t p LLCI ULCI 
Stigma to Self-efficacy -0.031 0.011 -2.83 0.0048 -0.053 -0.009 
Self-efficacy to Adh 1.828 0.577 3.16 0.0017 0.693 2.964 
Stigma to Adh (controlling for self-
efficacy) 
-0.332 0.104 -3.18 0.0016 -0.537 -0.127 
Gender -0.119 1.547 -0.077 0.9385 -3.161 2.922 
Self-efficacy x gender -2.559 1.177 -2.16 0.0302 -4.873 -0.246 
Stigma x gender 0.022 0.219 0.10 0.9196 -0.409 0.454 
 
Conditional direct effect of stigma on adherence at values of the moderator (male/female) 
 
Moderator Coeff. SE t p BootLLCI BootULCI 
Male -0.342 0.041 -1.895 0.0588 -0.697 0.0128 
 Female -0.320 0.026 -2.564 0.0107 -0.565 -0.074 
 
Conditional indirect effect of stigma on adherence at values of the moderator (male/female) 
Mediator Moderator Coeff. Boot SE   Boot LLCI BootULCI 
Self-efficacy Male -0.105 0.041   -0.213 -0.042 
Self-efficacy Female -0.025 0.026   -0.094 0.014 
 
Index of moderated mediation 
Mediator Index  SE (Boot)  BootLLCI BootULCI 
Self-efficacy 0.079  0.043  0.017 0.198 
 
 Adh: adherence, SE: standard error 
a
 Controlling for age, educational status, period known HIV-positive 
 
 
Table 5. Coefficients and Confidence Intervals for Stigma, Self-Efficacy, Stigma, and Art Adherence in The 




 Coeff. SE T p LLCI ULCC 
Stigma to self-efficacy -0.030 0.011 -2.78 0.0057 -0.053 -0.009 
Self-efficacy to adherence 1.616 0.577 2.80 0.0053 0.482 2.749 
Stigma to adherence -0.317 0.091 -3.46 0.0006 -0.497 -0.137 
Self-efficacy X stigma 0.107 0.037 2.88 0.0042 0.034 0.179 
 
Conditional direct effect of stigma on ART adherence at values of self-efficacy 
 Self-efficacy Effect SE (Boot) t p BootLLCI BootULCI 
 Low -.457 0.089 -5.157 <0.001 -0.632 -0.283 
 Medium -.297 0.077 -3.868 0.0001 -0.448 -0.146 
 High -.136 0.102 -1.338 0.1815 -0.336 0.064 
 
Index of moderated mediation 
Mediator Index SE (Boot)  BootLLCI BootULCI 
Self-efficacy -0.003 0.002  -0.007 -0.001 
 
SE standard error 
a
 Controlling for age, educational status, period known HIV-positive 
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strapped (n= 5,000) 95% confidence intervals 
(CIs) for males did not straddle zero, sig-
nifying a significant effect. However, the CIs 
for females were zero, depicting non-signifi-
cant effects. For the direct effect of stigma on 
ART adherence, the analysis tested the mode-
rating effect (conditional direct effect) bet-
ween depression and ART adherence at differ-
rent levels (male vs. female). The results re-
vealed that gender moderated the relation with 
females (B= -0.59, BootLLCI= -1.18, Boot-
LLCI= -0.01) only but not males (B= -0.20, 
BootLLCI= -0.82, BootLLCI= 0.42). The 
bootstrapped (n= 5000) 95% CIs for females 
did not straddle zero, portraying a significant 
effect. By contrast, the CIs for males were ze-
ro, depicting a non-significant effect. All cova-
riate effects were not statistically significant in 
terms of age (B= 0.46, p= 0.08), education (B= 
1.33, p= 0.40), and time known HIV status 
(B= 0.20, p= 0.41). 
 
Hypothesis 4 posited that gender would mode-
rate both the direct and the mediational effects 
of self-efficacy on the relationship between 
stigma and ART adherence. Table 4 shows the 
results. First, focusing on the indirect effects, 
the analysis showed that stigma predicted self-
efficacy (B= -0.03, t= -2.83, P= 0.0048), indi-
cating that high scores of stigma predicted low 
levels of self-efficacy. The interaction term in 
the analysis, self-efficacy x gender, depicted 
that it significantly predicted ART adherence 
beyond the main effects of self-efficacy and 
gender, independently (B= -2.56, t= -2.17, P= 
0.0302).  
 
The analysis tested the indirect conditional 
analysis at the two levels (male vs. female). 
The results showed that self-efficacy served as 
a mediator in the relationship between stigma 
and ART adherence for males (B= -0.10, Boot-
LLCI= -0.21, BootLLCI= -0.04) only but not 
females (B= -0.03, Boot-LLCI= -0.09, Boot-
LLCI= 0.01). The 95% bootstrapped (n= 
5000) CIs for males did not straddle zero, re-
presenting significant effects, whereas the CIs  
for females contained zero, depicting non-
significant. Second, focusing on the direct ef-
fect of stigma on ART adherence, the ana-lysis 
tested the conditional direct effect bet-ween 
stigma and ART adherence at different levels 
(male vs. female). The results revealed that gen-
der moderated the relation, with females (B= -
0.32, BootLLCI= -0.56, BootLLCI= -0.07) 
only but not males (B= -0.34, BootLLCI= -
0.69, BootLLCI= 0.01). The 95% bootstrapped 
(n= 5000) confidence intervals for females did 
not straddle zero, representing a significant ef-
fect. By contrast, the CIs for males were zero, 
depicting non-significant effects. For the cova-
riates, age was statistically significant (B= 0.58, 
p= 0.03), whereas education (B= 1.24, p= 0.41) 
and time known HIV-positive status (B= 0.09, 
p= 0.69) were not significant. 
 
Hypothesis 5 postulated that the mediator 
(self-efficacy) would act as a moderator in the 
relationship between stigma and ART adhere-
nce. Table 5 shows that stigma predicted self-
effi-cacy with higher stigma scores predicting 
lower self-efficacy (B= -0.03, t= -2.78, P= 
0.005). To determine whether or not self-ef-
ficacy mediates the relationship between stig-
ma and ART adherence, the interaction term, 
stigma x self-efficacy, was assessed to see if it 
independently predicted ART adherence be-
yond the main effects of stigma and self-effi-
cacy. The results revealed that the interaction 
predicted ART adherence over and above the 
effects of stigma and self-efficacy (B= 0.11, t 
= 2.88, P= 0.004).  
 
We also tested, as per Hayes’ PROCESS 
model 74 guideline, whether self-efficacy si-
multaneously moderates the direct relationship 
between stigma and ART adherence. Self-
efficacy emerged as a significant moderator of 
the direct relationship between stigma and 
ART adherence. Using PROCESS model 1, 
we generated conditional direct effects (Table 
5). The coefficient for the interaction term 
(stigma x self-efficacy) is statistically different 
from zero (b= 0.111, p= 0049). 
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This study is possibly the first to examine the 
role of self-efficacy and gender in the rela-
tionships between depression and HIV-related 
stigma with ART adherence among adole-
scents and young people. The findings reveal a 
com-plex interplay among various factors in 
influ-encing ART adherence. On the basis of 
SAT, we examined whether or not self-effi-
cacy functions as a mediating mechanism in 
the relationship between depression and HIV-
related stigma with ART adherence. The find-
ings showed that self-efficacy mediates the 
relations between depression and stigma with 
ART adherence. Moderated mediation analysis 
revealed that gender moderated both the direct 
and indirect effects of depression and stigma 
on ART adherence where the mediational ef-
fects of self-efficacy were significant for males 
but not females. Moreover, gender moderated 
the direct effects of depression and stigma on 
ART adherence among females but not males. 
Stigma also moderated the indirect effects of 
stigma on ART adherence via self-efficacy. 
These findings highlight a unique association 
of factors previously understood only in their 
direct association with ART adherence among 
youth. 
 
Drawing on SAT, this study uniquely contri-
butes to the literature on ART medication ad-
herence among adolescents by presenting self-
efficacy’s complex association with various 
factors in influencing adherence in the context 
of stigma. The simultaneous role of self-effica-
cy as both a mediator and moderator in influ-
encing ART adherence highlights the impor-
tance of designing adherence interventions ba-
sed on strengthening self-efficacy. This study 
is among the first to examine the mediational 
influence of self-efficacy on the relationship 
between depression and stigma with ART ad-
herence among youth particularly in SSA. The 
current findings are consistent with previous 
studies among adult samples that found that 
self-efficacy mediates the relationship between 
depression and stigma with ART adherence 
(Cha, Erlen, Kim, Sereika, & Caruthers, 2008; 
Archiopoli, et al., 2016; Seghatol-Eslami, 2017). 
Depression and stigma appear to influence 
ART adherence through their effect on youth’s 
self-efficacy with respect to medication. Con-
sequently, self-efficacy may be diminished by 
symptoms of depression such as hopelessness, 
poor concentration, fatigue, and anhedonia 
(Wagner, et al., 2016). Similarly, stigmatized 
youth may internalize negative beliefs held in 
the community and develop self-defacing in-
ternal representations of themselves that result 
in demoralization, emotional distress, and di-
minished self-efficacy (Katz, et al., 2013). In 
turn, diminished self-efficacy negatively influ-
ences ART medication adherence. 
 
The current study provides strong evidence for 
gender differences in how depression and stig-
ma influence ART adherence both direct and 
indirectly. In the relationships between depres-
sion and stigma with ART adherence, the 
effects were mediated by self-efficacy among 
males but not females. Social cognitive theory 
(SCT) contends that the decision-making that 
underlies self-efficacy differs by gender (Chavez, 
Beltran, Guerrero, Enriquez, & Reyes, 2014). 
From this perspective, gender differences in 
medication self-efficacy result from cultural 
expectations and a gendered socialization pro-
cess that accords males and females differing 
tasks and activities. In applying SCT to the 
findings from our study, unlike males, females 
in Malawi are introduced to tasks associated 
with medication early in life as they are more 
often at home and also tasked with gendered 
activities that include caring for their siblings. 
These experiences possibly prepare them for 
better medicating themselves as well. Given 
such gender differences, interventions to incre-
ase ART adherence among adolescents must 
consider gender when assessing and strategi-
zing to improve medication self-efficacy. This 
task includes acknowledging the unique gen-
dered, contextual realities within which male 
versus female adolescents undertake self-me-
dication. Interventional efforts that bolster 
adolescents’ confidence to take their medica-
Umar, et al., Depression, Stigma and ART Adherence 
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tions under different challenging conditions 
also are needed. 
 
The moderated mediation models tested and 
presented in this paper are based on cross-
sectional data. For this reason, causality cannot 
be established. For example, depression and 
stigma may work together to reduce ART 
adherence, but the opposite could also be true. 
Better ART adherence produces a lesser like-
lihood of depression and stigma. 
 
Although the sample was randomly drawn 
from ART registers at a hospital in each of the 
six districts, it does not represent a random 
sample for each district. For example, the stu-
dy sample does not include youth who regis-
tered and received ART in district clinics not 
included in the study’s sampling frame. None-
theless, by using a large sample and range of 
district hospitals in the southern region (6 out 
of 13), the sample likely comes close to re-
presenting the HIV epidemic among youth in 
southern Malawi and those accessing ART in 
public hospitals in the country’s southern re-
gion. In terms of sample representation, for 
ethical reasons, the health workers per district 
compiled randomly selected potential subjects 
and contacted them independent of the study’s 
research team. No information exists on how 
many potential subjects were approached and 
declined. 
 
Most instruments used in this study were ad-
apted or validated in Malawi with adults but 
not with the country’s young people living 
with HIV. Rigorous translation-back-transla-
tion was used to help ensure the instruments’ 
validity, although this method does not fully 




Understanding the interplay of various factors 
in influencing ART adherence is crucial to the 
development of viable interventions. To redu-
ce the effects of depression and stigma on 
ART adherence, medication self-efficacy must 
be bolstered while taking gender in conside-
ration. Further research may unravel additional 
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